Product NDC: | 53270-3120 |
Proprietary Name: | WINRHO |
Non Proprietary Name: | rho (d) immune globulin |
Active Ingredient(s): | 600 [iU]/mL & nbsp; rho (d) immune globulin |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 53270-3120 |
Labeler Name: | Cangene bioPharma Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103649 |
Marketing Category: | BLA |
Start Marketing Date: | 20050331 |
Package NDC: | 53270-3120-1 |
Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (53270-3120-1) > .5 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 53270-3120-1 |
Proprietary Name | WINRHO |
Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (53270-3120-1) > .5 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 53270-3120 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | rho (d) immune globulin |
Dosage Form Name | LIQUID |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20050331 |
Marketing Category Name | BLA |
Labeler Name | Cangene bioPharma Inc. |
Substance Name | HUMAN IMMUNOGLOBULIN G |
Strength Number | 600 |
Strength Unit | [iU]/mL |
Pharmaceutical Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |